Using pharmacies to provide buprenorphine and HIV services
Feasibility of pharmacy-delivered patient navigation + virtual buprenorphine + HIV services
This study is looking at how local pharmacies can provide quick and easy access to treatments for opioid addiction and HIV prevention, especially in neighborhoods like Harlem and the South Bronx, to help people get the care they need even during tough times like the COVID-19 pandemic.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University School of Medicine NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10874784 on NIH RePORTER |
What this research studies
This research explores how independent pharmacies can deliver on-demand harm reduction services, including telemedicine-based buprenorphine treatment and HIV prevention services, in underserved communities like Harlem and the South Bronx. By leveraging the NYC Health+Hospitals Virtual Buprenorphine Clinic, the project aims to improve access to opioid use disorder treatment and HIV services during disruptions caused by COVID-19. The approach focuses on integrating these services within pharmacies to enhance patient linkage and retention in care.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals in Harlem and the South Bronx who are struggling with opioid use disorder or are at risk for HIV.
Not a fit: Patients who do not reside in the targeted communities or those who are not affected by opioid use disorder or HIV may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve access to critical opioid use disorder and HIV prevention services for patients in underserved communities.
How similar studies have performed: Previous research has shown success in pharmacy-based interventions for public health, indicating a promising potential for this novel approach.
Where this research is happening
New York, United States
- New York University School of Medicine — New York, United States (Active)
Researchers
- Principal investigator: Lewis, Crystal Fuller — New York University School of Medicine
- Study coordinator: Lewis, Crystal Fuller
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.